These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19625402)

  • 21. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.
    Poon B; Chang MA; Chen IS
    J Virol; 2007 Oct; 81(19):10515-23. PubMed ID: 17652391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.
    Forouzanfar F; Ali S; Wallet C; De Rovere M; Ducloy C; El Mekdad H; El Maassarani M; Aït-Ammar A; Van Assche J; Boutant E; Daouad F; Margottin-Goguet F; Moog C; Van Lint C; Schwartz C; Rohr O
    Sci Rep; 2019 Sep; 9(1):13154. PubMed ID: 31511615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.
    Schröfelbauer B; Yu Q; Zeitlin SG; Landau NR
    J Virol; 2005 Sep; 79(17):10978-87. PubMed ID: 16103149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZBTB2 represses HIV-1 transcription and is regulated by HIV-1 Vpr and cellular DNA damage responses.
    Bruce JW; Bracken M; Evans E; Sherer N; Ahlquist P
    PLoS Pathog; 2021 Feb; 17(2):e1009364. PubMed ID: 33635925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages.
    Chen R; Le Rouzic E; Kearney JA; Mansky LM; Benichou S
    J Biol Chem; 2004 Jul; 279(27):28419-25. PubMed ID: 15096517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of HIV-1 Vpr manipulation of the DNA repair enzyme UNG2 on B lymphocyte class switch recombination.
    Eldin P; Péron S; Galashevskaya A; Denis-Lagache N; Cogné M; Slupphaug G; Briant L
    J Transl Med; 2020 Aug; 18(1):310. PubMed ID: 32778120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome.
    Li G; Elder RT; Dubrovsky L; Liang D; Pushkarsky T; Chiu K; Fan T; Sire J; Bukrinsky M; Zhao RY
    PLoS One; 2010 Jun; 5(6):e11371. PubMed ID: 20614012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.
    Dehart JL; Planelles V
    J Virol; 2008 Feb; 82(3):1066-72. PubMed ID: 17855541
    [No Abstract]   [Full Text] [Related]  

  • 29. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells.
    Iijima S; Nitahara-Kasahara Y; Kimata K; Zhong Zhuang W; Kamata M; Isogai M; Miwa M; Tsunetsugu-Yokota Y; Aida Y
    Virology; 2004 Oct; 327(2):249-61. PubMed ID: 15351213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest.
    Liang Z; Liu R; Lin Y; Liang C; Tan J; Qiao W
    Virol Sin; 2015 Dec; 30(6):441-8. PubMed ID: 26676942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.
    DeHart JL; Zimmerman ES; Ardon O; Monteiro-Filho CM; Argañaraz ER; Planelles V
    Virol J; 2007 Jun; 4():57. PubMed ID: 17559673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.
    Romani B; Kamali Jamil R; Hamidi-Fard M; Rahimi P; Momen SB; Aghasadeghi MR; Allahbakhshi E
    Sci Rep; 2016 Aug; 6():31924. PubMed ID: 27550312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Vpr redirects host ubiquitination pathway.
    Arora S; Verma S; Banerjea AC
    J Virol; 2014 Aug; 88(16):9141-52. PubMed ID: 24899191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.
    Zhu Y; Gelbard HA; Roshal M; Pursell S; Jamieson BD; Planelles V
    J Virol; 2001 Apr; 75(8):3791-801. PubMed ID: 11264368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.
    Belzile JP; Duisit G; Rougeau N; Mercier J; Finzi A; Cohen EA
    PLoS Pathog; 2007 Jul; 3(7):e85. PubMed ID: 17630831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages.
    Jacquot G; Le Rouzic E; David A; Mazzolini J; Bouchet J; Bouaziz S; Niedergang F; Pancino G; Benichou S
    Retrovirology; 2007 Nov; 4():84. PubMed ID: 18039376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 accessory proteins: VpR.
    Zhao RY; Bukrinsky MI
    Methods Mol Biol; 2014; 1087():125-34. PubMed ID: 24158819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.
    Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest.
    Selig L; Benichou S; Rogel ME; Wu LI; Vodicka MA; Sire J; Benarous R; Emerman M
    J Virol; 1997 Jun; 71(6):4842-6. PubMed ID: 9151883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Uracil-DNA Glycosylase UNG2 a New Cellular Weapon Against HIV-1?
    Kara H; Chazal N; Bouaziz S
    Curr HIV Res; 2019; 17(3):148-160. PubMed ID: 31433761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.